Literature DB >> 3089712

Secretion of toxic oxygen products by macrophages: regulatory cytokines and their effects on the oxidase.

C F Nathan, S Tsunawaki.   

Abstract

We are attempting to identify cytokines that regulate macrophage secretion of reactive oxygen intermediates (ROI) and to analyse the biochemical basis of their effects. In both humans and mice, interferon-gamma (IFN-gamma) appears to be the chief factor secreted by clonally unselected lymphocytes that enhances macrophage oxidative metabolism and antiprotozoal activity. In vivo administration of recombinant IFN-gamma enhances the ROI secretory capacity of monocytes in humans, and the secretion of ROI and killing of protozoa by peritoneal macrophages in mice. A protein secreted by murine tumours and certain non-malignant cells exerts opposing effects. This macrophage deactivation factor (MDF) both blocks the induction of activation by IFN-gamma and reverses pre-existent activation. MDF action is non-toxic and selective, suppressing the secretion of ROI, killing of intracellular protozoa, and expression of Ia antigen, without inhibiting secretion of several other products, or synthesis of protein, ingestion of particles or adherence to culture vessels. The suppressive effect of MDF is reversed over several days after its removal. This reversal is hastened by IFN-gamma. Profound suppression of oxidative metabolism accompanies the differentiation of murine monocytes into Kupffer cells. The capacity of Kupffer cells to secrete ROI and kill intracellular protozoa remains deficient even after exposure to IFN-gamma. Thus, four states of macrophage activation can provisionally be discerned: the transition of mouse peritoneal macrophages from the non-activated to the activated state is accompanied by a ninefold increase in affinity of the superoxide-producing enzyme for NADPH, without a marked increase in cellular Vmax or content of cytochrome b559. The MDF-induced transition of mouse peritoneal macrophages from the activated to the deactivated state is accompanied by both an increase in Km and a decrease in apparent V max of the oxidase. There are no changes in the phorbol myristate acetate receptor number or affinity, glucose transport, NADPH levels, cytochrome b559 content, catalase (EC 1.11.1.6) GSH, GSH peroxidase (EC 1.11.1.9), GSH reductase (EC 1.6.4.2) or myeloperoxidase, consistent with the suppressed ROI secretory capacity and antiprotozoal activity of these cells. The Kupffer cell, whose non-responsiveness to IFN-gamma may mark it as inactivated, appears to lack detectable NADPH oxidase activity, despite the probable presence of cytochrome b559, and in this regard differs from both non-activated and deactivated macrophages.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3089712     DOI: 10.1002/9780470720998.ch14

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  24 in total

1.  Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism.

Authors:  K Prasad; S V Mantha; A D Muir; N D Westcott
Journal:  Mol Cell Biochem       Date:  2000-03       Impact factor: 3.396

2.  Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

Authors:  R A Ezekowitz; S H Orkin; P E Newburger
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

3.  Ultrastructural localization of cytochrome b in the membranes of resting and phagocytosing human granulocytes.

Authors:  A J Jesaitis; E S Buescher; D Harrison; M T Quinn; C A Parkos; S Livesey; J Linner
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

4.  Expression of the X-CGD gene during induced differentiation of myeloid leukemia cell line HL-60.

Authors:  K A Barker; S H Orkin; P E Newburger
Journal:  Mol Cell Biol       Date:  1988-07       Impact factor: 4.272

Review 5.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 6.  New perspectives in chronic granulomatous disease.

Authors:  R A Ezekowitz; P E Newburger
Journal:  J Clin Immunol       Date:  1988-11       Impact factor: 8.317

7.  Total oxidative/anti-oxidative status and relation to bone mineral density in osteoporosis.

Authors:  Ozlem Altindag; Ozcan Erel; Neslihan Soran; Hakim Celik; Sahabettin Selek
Journal:  Rheumatol Int       Date:  2007-09-06       Impact factor: 2.631

8.  Cytotoxic effects of cytokines on rat islets: evidence for involvement of free radicals and lipid peroxidation.

Authors:  A Rabinovitch; W L Suarez; P D Thomas; K Strynadka; I Simpson
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

9.  Respiratory burst capacity of activated macrophages is resistant to depression by erythrocyte phagocytosis.

Authors:  M G Schwacha; D J Loegering
Journal:  Inflammation       Date:  1992-08       Impact factor: 4.092

Review 10.  Clinical islet cell transplantation. Are we there yet?

Authors:  L Rosenberg
Journal:  Int J Pancreatol       Date:  1998-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.